Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

histologically confirmed ovarian cancer or tube cancer or primary peritoneal carcinoma stage FIGO III
primary optimal debulking surgery
postoperative gross residual tumor ≤ 1cm ( R0, R1 oder R2 \< 1cm situation)
adjuvant chemotherapy with platin and taxane
complete remission after chemotherapy
Karnofsky performance score \> 60
patients \>18 years of age
written informed consent

stage FIGO I or II
stage III with postoperative gross residual tumor \> 1cm
stage FIGO IV
recurrence situation
delayed wound healing post laparotomy
leucopenia \<2000/ml before radiotherapy
thrombocytopenia \<75000/ml before radiotherapy
clinically active renal, hepatic, cardiac, metabolic, respiratory, coagulation or hematopoietic disease
status post pelvic or abdominal radiotherapy
status post other cancer disease in the past 5 years (cervical cancer in situ, basal cell carcinoma, squamous cell carcinoma of the skin are excluded)
participation in another clinical trial

Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer